Alex Zhavoronkov: Live Long and Prosper
The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.
What if We Didn’t Have to Test New Drugs on Animals?
As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.
More At-Home Tests Are Heading Your Way
A new wave of spit-and-swab home testing kits promises to give individuals more control over their own health.
Perspective: Should I Get the New COVID-19 Bivalent Booster?
Our writer unpacks the data behind the new vaccines and wonders what happened to nuance in the CDC’s recommendations.
Decentralized Science is Poised to Disrupt… Well, Everything
How DeSci, DAOs, and NFTs will change research funding, intellectual property, and collaboration.
What Will It Take to Decolonize Artificial Intelligence?
Workforce diversity, collective oversight, and day-to-day algorithm monitoring are all necessary to mitigate inherent bias.
New Microchip Based on Biomolecules is No Alien Technology
Roswell Biotechnologies wants you to believe its new chip will revolutionize the detection of viruses, DNA, and more. But it still has to prove itself.
Waiting for the Unicorns of Sh*t
Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?
The Big Business of Workplace Mindfulness
Corporate America is embracing mindfulness more than ever as the pandemic rages. But what do they mean by “mindfulness,” and does it work?